Amiprox

Founded in 2022, Amiprox has a vision to streamline, standardize and automate laboratory workflows using centrifugal spin devices.  Amiprox develops innovative proteomics sample preparation solutions designed to make biomarker discovery faster, simpler and more reproducible.  Built by scientists with a deep understanding of proteomics workflows, Amiprox's mission is to transform sample preparation from a laboratory bottleneck into a catalyst for discovery. Its products are designed to deliver speed, precision and simplicity, helping researchers move efficiently from biological sample to meaningful data.

Amiprox's flagship technology, ProtiPrep™, is a centrifugal microspin tube solution for the depletion of highly abundant plasma proteins. Unlike traditional depletion methods that require multiple wash and elution steps, specialised equipment and lengthy workflows, ProtiPrep™ enables plasma protein depletion in approximately 10 minutes through a simple, streamlined process. This approach improves workflow efficiency, reduces variability and increases laboratory throughput.

Designed for modern proteomics laboratories, Amiprox products support the detection of low-abundance biomarkers that are often critical for translational research, diagnostics development and biomarker discovery programmes. By combining intuitive product design, rigorous quality testing and affordability, Amiprox helps make precision proteomics more accessible to academic, biotechnology and pharmaceutical researchers.

Europa Biosite subsidiaries distribute Amiprox products in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and the United Kingdom.